This inventor holds 1 USPTO granted patent. Top assignee: Equispharm Co., Ltd. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Tae-Bo Sim
Introduction
Tae-Bo Sim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications in cancer treatment and inflammatory diseases.
Latest Patents
One of Tae-Bo Sim's notable patents is related to fumagillol derivatives and their preparation methods. This patent describes a fumagillol compound that serves as an angiogenesis inhibiting agent, demonstrating superior efficacy with reduced toxicity. The compound is not only useful in inhibiting cancer metastasis but also serves as a therapeutic agent for various inflammatory diseases, including rheumatic disease, psoriasis, and diabetic retinopathy.
Career Highlights
Tae-Bo Sim is associated with Equispharm Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on developing compounds that can significantly improve patient outcomes in cancer and other inflammatory conditions.
Collaborations
Some of his notable coworkers include Cheol-Kyu Han and Jeong-Hyeok Yoon, who collaborate with him on various research projects aimed at advancing medical treatments.
Conclusion
Tae-Bo Sim's work exemplifies the impact of innovative research in the pharmaceutical field. His contributions, particularly in the development of fumagillol derivatives, highlight the potential for new therapies in combating cancer and inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile